Although proton pump inhibitors may reduce heartburn and gastrointestinal bleeding in hospital patients, the therapy may also raise their mortality risk, according to a recent study published in the ...

New research shows PPIs can limit fibrosis in eosinophilic oesophagitis, offering potential disease-modifying effects. Learn more about PPI therapy.

The basis for these questions is the fact that levels of all 3 of these substances (hormones, vitamins, and elements) are in some way dependent on or related to gastric acid secretion. As such, any ...

Objective: To systematically review studies qualitatively to compare the risks (gastrointestinal [GI] and cardiovascular) and benefits (pain control) of cyclooxygenase-2 inhibitors (coxibs) relative ...

Proton pump inhibitor (PPI) use in patients with chronic obstructive airway diseases is associated with an increased exacerbation risk.

PPIs reduce gastric ulters (shown) but may weaken bones Taking PPIs for several years can significantly raise the risk of osteoporosis-related fracture. Researchers have good news and bad news for ...

The potential link between use of proton pump inhibitors and gastric cancer has been an ongoing controversial subject since the drugs entered the market in the late 1980s. Long-term use of proton pump ...

The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds ...

Significantly lower rates of symptom rebound and rebound severity seen four weeks after eradication for those with infection. HealthDay News — For patients with gastroesophageal reflux disease (GERD), ...